CURRICULUM VITAE
Name
: PRASAD NARAYANAN
Date of Birth
: 30th September 1975
Present Address
: Dr.Prasad Narayanan
Consultant Medical Oncologist at Mazumdar Shaw Cancer
Center and Narayana Hrudayalaya Multispecialty Hosptial
No 258/A, Bommasandra Industrial Area, Anekal Taluk,
Bangalore 560099
Phone Off: 91-80-27835000 to 18
Mobile-09902599881
Fax:
91-80-27832648
Email: prasadnarayanan@yahoo.com
prasad@hrudayalaya.com
Permanent Address
: C/o Mr. A Narayanan
TD Nagar 55
Anantavilas
TDRoad
Kollam, Kerala - 691013
Telephone: (+91)-474- 2793563
Mobile - 09446525866
Alternate address
: B 004, Block B, Daddy Garden, Kammasandra, Hebbagudi,
Electronic City post, 560100
Email: prasadoncology@gmail.com
prasadnarayanan@yahoo.com
EDUCATIONAL QUALIFICATIONS:
Institutions
Year
Certificate
Catalyst Clinical Services
2008
Professional Diploma in
Clinical Research
European Society of Medical Oncology
2007
ESMO certification in
Medical oncology
Tata Memorial hospital, Mumbai
2003-2007
D.M. (Med Oncology)
NSCB Medical College, Jabalpur, Madhya Pradesh
2000-2003
M.D. (Gen MD)
Govt. Medical College, Trivandrum
1993-1998
M.B.B.S
LICENSURE
: Medical Council of India (Kerala)
Registration No. 27995
Maharashtra Medical Council
Registration No 2004/01/219
MEMBER
: ESMO (European Society of Medical Oncology)
: ICON (Indian Cooperative Oncology Network)
PRESENT APPOINTMENT
Consultant Medical Oncologist at Mazumdar Shaw Cancer Center and Narayana Hrudayalaya Multispecialty
Hosptial (The cancer Institute is one of the largest cancer centers in the world with state of art medical, radiation and
surgical oncology departments with site specific focused cancer care)
CLINICAL TRAINING AND PROFESSIONAL EXPERIENCE
1.
2.
Assistant Professor in Medical Oncology at Amrita Institute of Medical Sciences, Cochin from March 2007 to
May 2009.
Specialist Registrar in the department of Medical Oncology at Tata Memorial Centre.Mumbai from October
2006- February 2007.
3.
Senior resident in the department of Medical Oncology, Tata Memorial Hospital, Mumbai. Carried out
autologous and allogenic BMT as part of training (2003-2006).
4.
Junior resident in the department of Internal Medicine, NSCB Medical College, Jabalpur, Madhya Pradesh
(2000-2003).
5.
One year compulsory rotating internship at Trivandrum Medical College, Trivandrum, Kerala, including 3
months at an attached community hospital. Rotation in various clinical departments at Trivandrum Medical
College (1998-1999)
TEACHING EXPERIENCE
1.
2.
3.
DNB trainees/ medical students/ nursing students in the department of medical oncology at Amrita institute of
medical sciences, Cochin (2007 - 2009).
Junior residents and oncology nursing students as Senior Resident, Medical Oncology, Tata Memorial Hospital,
Mumbai (20003-2007).
Medical students as Junior Resident, Internal Medicine, NSCB Medical College, Jabalpur, Madhya Pradesh
(2000-2003).
MAJOR INTERESTS
1.
2.
3.
4.
Clinical research
Stem cell transplantation
Head and neck and breast cancer
Paediatric Oncology
OTHER ACADEMIC ACTIVITIES/ ACHIEVEMENTS
Contributed as Author in chapter titled “ Role of chemotherapy in the management of Head and Neck squamous
cell cancer in AHEAD education book 2008.
2. Contributed as Author in chapter titled “Treatment of Non Small Cell Lung” In ‘The Oncology Knowledge
Bank’ Vol 2, 2008.
3. Contributed as Author in chapter titled “Treatment of Lung Cancer in the Elderly” In ‘The Oncology
Knowledge Bank’ Vol 1, 2006.
4. Won first prize for the Best Thesis competition in ICON conference held in Trivandrum September 2006.
5. Submitted a Project Titled “CD 26 expression and its correlation with engraftment In hematopoietic stem cell
transplant” for ACORD workshop in Queensland Australia in September 2006. Got an International Travel
Grant and Scholarship to attend the same.
6. Second Prize in Debate Competition in 14th ICON Conference held in April 2006.
7. Participated as a Delegate during the Workshop on Preparing Cochrane Reviews held at Tata Memorial
Hospital, Mumbai in March 2005.
8. First Prize in Quiz Competition in Mumbai Hematology Group annual meeting 2005 held in TMH Mumbai.
9. Completed the Cardiopulmonary Resuscitation Provider Course Conducted by the Department of Anaesthesia,
Tata Memorial Centre in March 2004.
10. Conducted Quiz Competition in Mumbai Hematology Group annual meeting 2004 held in SION hospital
Mumbai.
11. Second Prize in Quiz Competition in MPICON 2002.
1.
CONFERENCES ATTENDED
1. Faculty moderator for panel discussion in FHNO 2009 at Kochi in October 2009.
2. Faculty for ICON 2009 in Mumbai September 2009.
3. Faculty for ISMPO Best Of ASCO Symposium in Bangalore August 2009.
4. Organised the CME in Heamato oncology at Narayana Hrudayalaya August 2009.
5. Faculty lecture on Chemotherapy at Rajiv Gandhi Health University Bangalore July 2009.
6. Delivered lecture in Asia Pacific Lung Cancer Conference in Hyderabad in December 2008.
7. “From Clinical Research to publication” by John Hopkins University at Singapore in August 2008.
8. First Asia Pacific EGFR Advisor’s Network (EAN) meeting in July 2008 at Hongkong.
9. Faculty in ICON conference in Bhubaneshwar in March 2008.
10. Delivered lecture in AHEAD 2008 meeting in AIMS Kochi in Feb 2008.
11. Attended as Faculty at ISMPO meeting in Bhutan on Febrile Neutropenia.
12. SIOP (International Society of Pediatric Oncology) conference in Mumbai 2007.
13. Evidence Based Meeting in Tata Memorial Centre in February 2007.
14. Participated in International Update of Hematology January 2007.
15. ICON conference in Trivandrum September 2006.
16. Participated in ACORD Australia in August 2006.
17. ICON conference in Dehradun April 2006.
18. Participated in the International Update on Multiple Myeloma held at Bombay Hospital in January 2006.
19. Participated as speaker in Chemotherapy Workshop at Tata Memorial Centre in December 2005.
20. International Update in Haematology at Bombay Hospital in September2005.
21. APICON 2005 in Mumbai.
22. ASCO 2005 May 13-17 in Orlando, Florida.
23. 3rd conference of Federation of Oncologists of SAARC Countries in April 2005.
24. XI th National CME in haematology in Bombay Hospital in April 2005.
25. EBM 2005 in Tata Memorial Centre in February 2005.
26. International Update on Hematological Malignancies in Mumbai on January 2005.
27. ASH-2004 update in Mumbai on 30th January 2005.
28. International Conference on Human Genome Update in Hyderabad in August 2004.
29. 28th Annual Conference of Mumbai Hematology Group in Mumbai, in March 2004.
30. ASH-2003 update in Mumbai on 1st February 2004.
31. Evidence Based Meeting at Tata Memorial Hospital, Mumbai, in February 2004.
32. Attended Evidence Based Meeting at Tata Memorial Hospital, Mumbai, in Feb 2003.
33. Attended MPICON, Madhya Pradesh 2002.
RESEARCH EXPERIENCE
1.
2.
3.
4.
5.
Submitted the MD thesis titled "Microalbuminuria in NonDiabetic Myocardial Infarction" under Prof M.K.
Parashar (MD Thesis 200-2003).
Participated in a clinical trial ' An evaluation of safety and efficacy of G-CSF in prevention of neutropenia in
patients receiving cancer chemotherapy '. Protocol IPL-IBT-P1-02 (2004).
Participated in A Phase III randomized, open label study of IV edotecarin vs temozolamide or carmustine or
lomustine in patients with glioblastoma multiforme. Edoagl-8725-001 (2004).
Participated in a double blind, placebo controlled, parallel, multicentre, randomized, phase III survival study
comparing Iressa to Best supportive care in advanced NSCLC. 18391L/0709 (2004).
Submitted the DM thesis titled “Advanced NSCLC (Stage IIIB and Stage IV). Efficacy and safety evaluation
of Low Dose Prolonged Infusion Gemcitabine and standard carboplatin doublet” under Dr Prof P.M.Parikh.
(DM Thesis 2003-2006).
STEM TRANSPLANT RELATED ACTIVITIES
Was actively involved in stem cell transplant related activities in TMH. Have done atleast 50 stem cell transplants
including Auto, Allo, Haplo and cord blood transplant. Also published/presented stem cell transplant related
activities in National and International venues.
1.
2.
3.
4.
5.
6.
7.
8.
Role of Itraconazole for prophylaxis of fungal infections in BMT setting [1032P]. Bakshi A, Goyal L,
Hingmire S, Mandhaniya S, Prasad N, Bajpai J, Bhagwat R, Mishra BK, Sastry PSRK, Parikh PM. 31 st
ESMO Congress, Istanbul, Turkey, September 29-October 3, 2006.
Prasad N, R Bhagwat, PSRK Sastry, H Gadade, G Biswas, A Khadwal,A Bakshi,PMParikh :Autologous
Stem Cell Transplantation in MM-A Single Institution experience :3rd Conference of Federation of
Oncologists of SAARC countries.
Prasad. N, Sastry PSRK, B.K.Mishra, Sushil M, Roshni Bhagwat, Ashish Bakshi, G Biswas, P.M.Parikh.
Outcome of Allogenic Stem Cell Transplant in CML analyzed according to the EBMT Score based risk
groups – A Single Institution Experience. Biology of Blood and Marrow Transplantation.
A Khadwal, Prasad N, G Biswas, R Bhagwat, A Bakshi, PSRK Sastry, P M Parikh ABO incompatibility in
allogenic SCT. Proceedings of 10th conference of APBMT.Oct 13-16,2005 China
PSRK Sastry, R Bhagwat, G Biswas, A Khadwal, Prasad N, A Bakshi, PM Parikh. Trial of amifostine in
autologous stem cell transplant. Bone Marrow Transplant. 2005 Nov 7.
R Bhagwat, A Khadwal, G Biswas, Prasad N, P Kulkarni, PSRK Sastry, A Bakshi, PM Parikh, Late
Infectious complications after hematopoietic stem cell transplantation. Proceedings of 10 th conference of
APBMT.Oct 13-16, 2005 China.
G Biswas, PSRK Sastry, Prasad N A Khadwal, R Bhagwat, A Bakshi, S Basu, N Nair, PM Parikh. Response
Evaluation with FDG-PET pre and post ASCT in lymphoma. Proceedings of 10 th conference of APBMT.Oct
13-16, 2005 China.
Submitted a Project Titled “CD 26 expression and its correlation with engraftment In hematopoietic stem cell
transplant”. This was developed in ACORD workshop in Queensland, Australia and has been cleared by TMH
scientific and ethics committee.
CLINICAL TRIALS
Has been a part of multiple Phase I, II, III, IV trials at Amrita Institute of Medical Sciences as Principal
Investigator and Co – Investigator.
1.
2.
3.
4.
5.
6.
7.
8.
9.
Principal Investigator: NU 07B1: A Double-Blind, Randomized Phase 2b Study Evaluating the
Efficacy and Safety of Sorafenib Compared to Placebo when Administered in Combination with
Paclitaxel in Patients with Locally Recurrent or Metastatic Breast Cancer.
Principal Investigator: L00070 IN 305 B0: A phase III trial of vinflunine + capecitabine versus
capecitabine alone in patients with advanced breast cancer previously treated with or resistant to an
anthracycline and who are taxane resistant
Co- Investigator: H3E-MC-JMHR: A Randomized Phase 3 Study of Pemetrexed in Combination with
Cisplatin Versus Cisplatin Monotherapy in patients with Recurrent or Metastatic Head and Neck
Cancer.
Co- Investigator: FM-CL1: A Phase I/IIa, Open-Label, Dose-Escalation Study to Determine the
Safety, Tolerance, and Preliminary Activity of Intravenous High-Dose Fluphenazine HCl in Patients
with Advanced Multiple Myeloma.
Co- Investigator: EGF102988: Randomized phase III study of adjuvant postoperative lapatinib with
concurrent chemotherapy and radiation therapy in patients with SCCHN.
Co- Investigator: EGF110656: A Phase III Study of Erbb2 Positive Advanced or Metastatic Gastric or
Esophageal or Gastroesophageal Junction Adenocarcinoma Treated With Capecitabine Plus
Oxaliplatin With Or Without Lapatinib.
Co- Investigator: EFC6521: A multinational, randomized, double-blind, placebo-controlled study to
evaluate the efficacy and safety of AVE5026 in the Prevention of Venous Thromboembolism (VTE) in
cancer patients at high risk for VTE and who are undergoing chemotherapy.
Co- Investigator: A4061032: AXITINIB (AG-013736) as Second Line Therapy for Metastatic Renal
Cell Cancer: AXIS TRIAL.
Co- Investigator: FM-CL2: Phase 1b Single Arm, Open Label, Multi-Center Study of Fluphenazine
HCl Monotherapy in Relapsed or Relapsed-and-Refractory Multiple Myeloma.
LECTURES & ORAL PRESENTATIONS
Delivered a lecture on ‘Systemic treatment of head and neck cancer ‘ at St Johns Medical College on 22
Feb 2010.
2. Delivered a Lecture on ‘Basics of Cancer Chemotherapy’ at Pan Africans e – network on 02 December
2009.
3. Moderated a panel discussion on role of chemotherapy in Head and Neck Cancer at IMA Hall Kochi as a
part of FHNO 2009 in October 2009.
4. Moderated the session on best project proposal at 21 st ICON meeting from 18th to 20th September 2009 at
Mumbai.
5. Delivered an invited lecture titled ‘ Induction chemotherapy in Head and Neck Cancer – present role and
future directions’ at 21st ICON meeting from 18th to 20th September 2009 at Mumbai.
6. Participated at ISMPOs Best of ASCO meeting on 8th and 9th August 2009 as faculty and chaired the
session on Non Small Cell Lung Cancer at Bangalore.
7. Organised the 2nd CME in Hemato – Oncolgoy with focus on Myeloma and lymphoma at Narayana Health
City on 1st August 2009
8. Delivered an invited lecture titled ‘ Recent advances in cancer chemotherapy and implications to future’ at
Symposium on Cancer Care at Rajiv Gandhi University of Health Sciences, Karnataka on 24/07/09.
9. Faculty lecture on ‘combining chemotherapy and targeted therapy in NSCLC – Lung Cancer Update
Mumbai June 2009.
10. Faculty lecture on Prognostic and Predictive markers in NSCLC at Asia Pacific Lung Cancer Conference in
Hyderabad in December 2008.
11. Faculty lecture on “Adjuvant chemotherapy in stomach cancer “ at ICON 2008 in March 2008.
1.
12. Faculty lecture “ Role of chemotherapy in head and neck cancer” at AHEAD 2008 meeting in AIMS
Kochi.
13. Faculty Panel discussion “ Neuroendocrine tumors of Pancreas” at AGOICON 2008 at Kochi.
14. Faculty lecture on ‘ G - CSF guidelines in Febrile neutropenia ‘ at ISMPO conference in Bhutan in
November 2007.
15. Vora T, Arora B, Goyal L, Prasad N, Padhye B, Mishra BK, Banavali S, Bhagwat R, Kelkar R, Biswas S,
Kurkure P, Parikh PM Clinico-bacteriologic profile of emerging super bugs in pediatric oncology patients:
experience from a tertiary care center in a developing country Submitted for SIOP 2006 meeting.
16. Lecture on ‘Recent advances in Cancer Chemotherapy’ in the Chemotherapy Workshop held in TMH on
2nd December 2005.
17. G Biswas, PSRK Sastry, N Prasad, A Khadwal,R Bhagwat, A Bakshi,S Basu,N Nair, PM Parikh.
Response Evaluation with FDG-PET pre and post ASCT in lymphoma. Proceedings of 10 th conference of
APBMT.Oct 13-16,2005 China.
18. R Bhagwat,A Khadwal,G Biswas, N Prasad, P Kulkarni,PSRK Sastry, A Bakshi,PM Parikh , Late
Infectious complications after hematopoietic stem cell transplantation . Proceedings of 10th conference of
APBMT.Oct 13-16,2005 China.
19. G Biswas, N Karanth, N Prasad, R Bhagwat, A Bakshi, D Maru, S Gujral, S Gupta, R Nair, PM Parikh:
Profile of Primary Thyroid NHL: 10 years experience: 3 rd Conference of Federation of Oncologists of
SAARC countries.
20. N Prasad, R Bhagwat, PSRK Sastry, H Gadade, G Biswas, A Khadwal, A Bakshi, PMParikh: Autologous
Stem Cell Transplantation in MM-A Single Institution experience: 3rd Conference of Federation of
Oncologists of SAARC countries.
21. G Biswas, PM Parikh, R Nair, R Bhagwat, A Bakshi, Prasad N, VR Pai, S Gupta: Rituximab in
lymphoproliferative malignancies: Single institutional experience. Mumbai Hematology Group Annual
meeting March 2005(Dr JC Patel Award session).
22. Khadwal, Prasad N, A V Bakshi, R Bhagwat, Sastry PSRK, Parikh PM: ABO incompatibility between
donor and recipient in allogenic stem cell transplantation: Does it impact outcome? A TMH experience.
Mumbai Hematology Group Annual meeting March 2005.
23. Prasad N, Goyal L, Biswas G, Bhagwat R, Kulkarni P, Nair R, Gupta S, Pai VR, Parikh P. Rituximab in
Non-Hodgkins Lymphoma - Tata Memorial Hospital experience , Mumbai. APICON, Jan 21-25, 2005.
24. Outbreak of Vancomycin Resistant Enterococcal infection in a tertiary centre at the Mumbai Hematology
Group monthly meeting in TMH - Jan 2005.
25. Prasad N, Nair R, Deshmukh C, Biswas G, Goyal L, Gupta S, Pai SK, Banavali S, Parikh P. Primary Non
Hodgkins Lymphoma of Bone- Tata Memorial Hospital experience, Mumbai. APICON, Jan 21-25, 2005.
26. Shanthi.N, Parikh PM, Prasad N. Assessment of the level of Anxiety and depression in newly diagnosed
cancer patients. Mumbai Hematology Group Annual meeting March 2004.
POSTERS PRESENTED
1. Boben T, Pavithran K, Manoj U, Prasad N, Kishore K, Abdul M, Shalini TP, Ganesan TS. Low dose
Thalidomide & Dexamethasone in previously untreated Multiple Myeloma. APICON Jan 2008; Cochin.
2. Boben T, Pavithran K, Manoj U, Prasad N, Kishore K, Abdul M, Shalini TP, Ganesan TS. Acute Myeloid
Leukaemia: Treatment Experiene at AIMS, Kochi, Kerala. Leukaemias: Molecular Insights to Treatment
Paradigms; 7-9, March 2008 Mumbai.
3. Prasad N, PM Parikh, Harimenon, Kumar Prabhash. Treatment of advanced stage NSCLC in elderly with low
dose prolonged infusion gemcitabine and standard dose carboplatin doublet. EBM conference Tata Memorial
Centre, February 2007.
4. Bakshi A, Goyal L, Hingmire S, Mandhaniya S Prasad N, Bajpai J, Bhagwat R, Mishra BK, Sastry PSRK,
Parikh PM. Role of Itraconazole for prophylaxis of fungal infections in BMT setting [1032P]. 31st ESMO
Congress, Istanbul, Turkey, September 29-October 3, 2006.
5. Arora B, Vora T, Padhye B, Mishra BK, Goyal L, Prasad N, Banavali S, Bhagwat R, Kurkure P, Nair CN, Pai
SK, Ganesh B, Parikh PM Pattern of malignancies in adolescents and young adults in a developing country:
Implications for outcome optimization and Health services management. Submitted for SIOP meeting 2006.
6. Arora B, Vora T, Padhye B, Mishra BK, Goyal L, Prasad N, Kurkure P, Sarin R, Jalali R, Gupta T, majumdar
D, Parikh PM Long-term survival and late effects in primary intracranial germ cell tumors IN INDIA.
Submitted for SIOP meeting 2006.
7. Arora B, Vora T, Padhye B, Mishra BK, Goyal L, Prasad N, Banavali S, Bhagwat R, Kurkure P, Nair CN,
Pay SK, Tongaonkar H, Maheshwari A, Yuvraj TB, Qureshi S, Laskar S3, Muckaden M3 Parikh PM Excellent
long-term survival but significant late morbidity in childhood germ cell tumors (CGCT): Perspectives from a
developing country. Submitted for SIOP meeting 2006.
8. B. Arora, Munira Chaphekar, Purna Kurkure, Shripad Banawali, Roshini Bhagwat, Hari Menon, Prasad N,
Geeta Sadani, PS Kadam, Chanda Baisane, Chetan Deshmukh, PSRK Sastry, PM, Parikh Efficacy and toxicity
profile of Imatinib Mesylate in chidren and young adults with CML: A single centre experience. 37th Annual
Conference of the international Society of Pediatric Oncology SIOP 2005, Vancouver, Canada. Abstract No:
P.J.009.
9. Prasad N, Sadani G, Amre Kadam P, C Deshmukh, AVBakshi, G Biswas, A Vora, H Menon, Sastry PSRK,
Parikh PM – Isolated CNS Relapse with complete cytogenetic and hematological response in blood and
bonemarrow in a case of CML BC: A case report. MHG 2005.
10. Prasad N, C Deshmukh, Kurkure P, Arora B, Banavali SD, Bhagwat R, H Menon, Sadani G, Amre Kadam
P, Baisane C, Sastry PSRK, Parikh PM: Use of Imatinib in children and young adults with CML – TMH
experience. MHG 2005.
11. VN Karanth, Prasad N, A V Bakshi, K Prabhash, H Menon, G Biswas, Pai VR, Vora A, Parikh PM:
Plasmacytoma of external auditory canal – case report. MHG 2005.
12. A Vora, P.M.Parikh, N.Shanthi, V.R.Pai, N.Prasad, S.Goswami, S.Shah. Role Of Hospital Anxiety and
Depression scale in reducing need of a formal psychiatric referral in cancer patients. ASCO 2005.
13. PSRK Sastry, R.Bhagwat, G.Biswas, PadmajKulkarni, Alka Khadwal, N Prasad, Ashish Bakshi, PMParikh.
Amifostine in autologous stem cell transplantation: comparative data with controls. ESMO 2005.
14. G Biswas, N Prasad, R Bhagwat, P Kulkarni, A Vora, Sarita Shah, PSRK Sastry, PM Parikh. Perceptions
about complementary and alternative (CAM) medicine in a tertiary oncology centre in India. ESMO Budapest
2005.
15. A Khadwal, N Prasad, G Biswas, R Bhagwat, A Bakshi, PSRK Sastry, P M Parikh ABO incompatibility in
Allogeneic SCT. Proceedings of 10th conference of APBMT.Oct 13-16, 2005 China.
16. Prasad N, Deshmukh C, A V Bakshi, Saikia T, Gupta S, Pai VR, Banavali SD, Kurkure PA, Parikh PM,
Dermatologic changes in 200 CML patients treated with Imatinib Mesylate -TMH experience. Annual
Conference of Mumbai Hematology Group March 2004.
17. Prasad N, Deshmukh C, A.V. Bakshi, A Vora, V.R.Pai, Parikh PM, Dermatological changes due to Imatinib TMH experience-International Conference Of Human Genome Update. Hyderabad -August 2004.
18. Khurana R, Biswas G, P kulkarni, Prasad N, Saikia T Nair R, Parikh P. Solitary Intracranial extraosseous
Plasmacytoma with multiple myeloma: A case report MHG, 2004.
PUBLICATIONS
1.
2.
3.
4.
5.
6.
7.
B. Thomas, K. Pavithran, N Prasad, M. Unni, K. Kumar, A. Majeed, T. S. Ganesan. A phase II study of low
dose thalidomide and dexamethasone in previously untreated multiple myeloma. J Clin Oncol 26: 2008 (May
20 suppl; abstr 19520).
S Hingmire, Prasad N, Alka Khadwal, D Maru, G Biswas, PSRK Sastry, PM Parikh..Isolated Cutaneous
Relapse Of Acute Myeloid Leukemia.JAPI Vol 55. February 2007.
Prasad. N, Prabash K, Parikh PM. Hepatocellular Carcinoma presenting as double head. Accepted for
publication in Indian Journal of Gastroenterology. Clarified on June 26, 2006.
A Bakshi, G Biswas, C Deshmukh, N Prasad, R Nair, PM Parikh. Successful complete regression of isolated
intramedullary spinal cord metastases from epithelial ovarian carcinoma with chemotherapy and radiotherapy.
Indian Journal of Cancer July 2006 issue.
SD Banavali, Lovenish Goyal, Roshni Bhagwat, Prasad N, Sushil Mandhaniya, Brijesh Arora, Amish Vora,
Suresh Pai, Sumeet Gujral, PA Kurkure, Melissa Adde, Ian Magrath, Purvish M Parikh. Vinblastine Based
Short Pulse B Non Hodgkins Lymphoma Type Chemotherapy with Maintenance Therapy is highly efficacious
Treatment for Anaplastic Large Cell Lymphoma (ALCL). ASH 2006.
Prabhash K, Biswas G, Prasad N, Karant N, Sastry PS, Parikh PM. Imatinib-induced nail hyper pigmentation
in chronic myeloid leukemia. Indian J Dermatol Venereol Leprol. 2006 Jan-Feb; 72(1): 63-4.
Khadwal A, Prasad N, Biswas G, Bhagwat R, Sastry PS, Parikh PM. Spontaneous migration of central
venous catheter tip. J Assoc Physicians India. 2006 Jan; 54:35.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
Biswas G, Prasad N, Bhagwat R, Khadwal A, Bakshi AV, Parikh PM. Thalidomide in primary peritoneal
mesothelioma. Thalidomide in primary peritoneal mesothelioma. J Surg Oncol. 2006 Apr 1; 93(5): 434.
Prabhash K, Prasad N, Biswas G, Parikh PM. Cutaneous metastasis from urologic
tumors. Indian J
Dermatol Venereol Leprol. 2006 Jan-Feb.
Biswas G, Bhagwat R, Khurana R, Menon H, Prasad N, Parikh PM. Brain Metastasis- Evidence based
management. A Review article. J Cancer Res Ther, March 2006 - Volume 2.
G Biswas, S Hingmire, IN Bagwan, N Prasad, A Bakshi, RF Chinoy, CN Nair. Primitive neuroectodermal
tumor (PNET) of thyroid – A case report. Oral Oncology Extra, May 2006.
Prasad N, Biswas G, Khadwal A, Prabash K, Parikh PM. Carcinoma Esophagus with Brain Metastasis. A
letter to Editor. Indian Journal of Medical and Pediatric Oncology, June 2006- Vol 27, No.2.
Prasad.N, Sastry PSRK, B.K.Mishra, Sushil M, Roshni Bhagwat, Ashish Bakshi, G Biswas,
P.M.ParikhOutcome of Allogenic Stem Cell Transplant in CML analyzed according to the EBMT Score based
risk groups – A Single Institution Experience. Biology of Blood and Marrow Transplantation.
Biswas G, Bhagwat R, Khurana R, Prasad N, Sastry PSRK, Parikh PM. Multiple Myeloma presenting as a
Suprasellar Plasmacytoma: A Pictorial CME. JAPI 2005; 53: 24.
Prasad N, C D Deshmukh, G Biswas, A Bakshi, PSRK Sastry, P M Parikh. Dermatological Toxicity of
Imatinib Mesylate: A Pictorial CME. JAPI 2005; Apr;53:298.
Prasad N, Chaya Dhoke, Breast Cancer - chemotherapy and nursing management. Oncology Nursing News
Letter Jan to March 2005. Vol 7. Issue1.
PM Parikh, Prasad N, R.C.Mistry, J.P.Agarwal, V.R.Pai, R.Nair, S.Gupta, P.S.Sastry, A Vora, K.A.Dinshaw:
Treatment of advanced NSCLC with low dose gemcitabine and carboplatin.-ASCO abstract book 2005.
K.Prabash, P.S.R.K Sastry, G Biswas, A Bakshi, Prasad N, H Menon & PM Parikh. Pregnancy outcome of
two patients treated with imatinib. Letter to editor. Ann Oncol. 2005 Aug 12.
Sastry P, Bhagwat R, Biswas G, Khadwal A, Prasad N, Bakshi A, Parikh P. Trial of amifostine in autologous
stem cell transplant. Bone Marrow Transplant.2005 Nov 7.
Purvish Parikh, C.D.Deshmukh, A.V.Bakshi, Prasad N, A Vora, V.R.Pai, P.A. Kurkure, R. Nair, S.K. Pai
Dermatological side effects of Imatinib Mesylate correlate with cytogenetic response in CML patients from
India. Annals of Oncology, Volt 15, Supplement 3, 2004.
LANGUAGES KNOWN
English, Hindi, Tamil and Malayalam
REFEREES
1.
Prof. Dr. PM.Parikh,
Medical Oncologist and Hematologist
Previously HOD, Dept. of Medical Oncology
Tata Memorial Hospital, Mumbai, Parel, 400012
purvish1@gmail.com
2.
Prof. Dr. Pavithran
Medical Oncologist and Hematologist
Head Dept. Medical Oncology
Amrita Institute Of Medical Sciences
Kochi
Kerala, India
pavithrank@aims.amrita.edu